Standout Papers

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial 2023 2026 202462
  1. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial (2023)
    Hamdi Jama, Michael Nakai et al. Nature Cardiovascular Research

Immediate Impact

63 standout
Sub-graph 1 of 22

Citing Papers

Gut microbiota-derived short-chain fatty acids and their role in human health and disease
2025 Standout
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
2 intermediate papers

Works of Rachel E. Climie being referenced

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
2023 Standout
Measuring the Interaction Between the Macro- and Micro-Vasculature
2019

Author Peers

Author Last Decade Papers Cites
Rachel E. Climie 628 222 336 82 1.2k
Daniel Courteix 277 197 497 93 1.3k
G Blümchen 515 260 418 47 1.6k
Anna Jegier 451 201 405 77 1.3k
Kenneth Madden 382 184 459 103 1.5k
Quan Huynh 672 204 220 73 1.3k
Toshiki Ohta 261 300 343 78 1.6k
William G. Herbert 461 162 421 68 1.4k
Jane Lindschou 473 250 220 79 1.7k
Chueh‐Lung Hwang 532 102 497 48 1.4k
Kieran Fallon 311 123 502 52 1.7k

All Works

Loading papers...

Rankless by CCL
2026